MUMBAI, Inde, 6 août 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a annoncé aujourd’hui ses résultats consolidés pour le premier trimestre (T1) clos le 30 juin 2023. Faits saillants des résultats financiers consolidés : (En crores INR) Détails T1 Exercice…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.